Goldman Sachs Reviews Biotech: Amgen, Celgene And Clovis Oncology

By: via Benzinga
Ahead of the May 29 American Society of Clinical Oncology conference, analysts at Goldman Sachs reviewed the outlook for some of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.